Skip to content

The CAVIAR-trial

Catheter ablation versus video assisted thoracoscopic surgery for the treatment of (longstanding) persistent atrial fibrillation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON20520
Enrollment
60
Registered
2015-03-03
Start date
2015-08-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Persistent and longstanding persistent atrial fibrillation

Interventions

-Catheter ablation -Surgical ablation

Sponsors

University Medical Center Utrecht (UMCU)
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: - Patients age is > 18 years - Patients with persistent or longstanding persistent atrial fibrillation. Persistent AF is defined as sustained episodes of atrial fibrillation lasting >7 days. Longstanding persistent AF is defined as sustained episode lasting >1 year. - Patients undergoing a first time invasive treatment procedure for persistent atrial fibrillation - AF must be recorded at least once by ECG, holter, telemetry, loop recorder or internal device. - Patients must give informed consent to participate

Exclusion criteria

Exclusion criteria: - Patients suffering from paroxysmal atrial fibrillation. Paroxysmal AF is defined as episodes of AF that terminates spontaneously within 7 days. - Patients suffering from AF secondary to a reversible cause as electrolyte imbalance or hyperthyroidism. - Body mass index >40 - Active infection or sepsis - Unstable angina, myocardial infarction within the previous 6 months - Patients with any contra-indications for electrophysiologic study and ablation in the left atrium: -pregnancy -presence of a left atrial thrombus - Patients with any contra-indications for video assisted thoracoscopic surgery: - prior lung/cardiac surgery - pleural adhesions - elevated hemidiaphragm - mitral or aortic valve regurgitation above grade 2 - moderate to severe mitral or aortic stenosis

Design outcomes

Primary

MeasureTime frame
The primary objective of the study is to evaluate which treatment- surgical ablation or catheter ablation- is most effective in treating persistent and longstanding persistent atrial fibrillation measured by success at 12 months after 1 procedures.

Secondary

MeasureTime frame
The incidence of periprocedural complications, clinical success after 12 months, procedural duration, number of repeat procedures, success and clinical success after 2 procedure after 12 months, quality of life measurements before and 6 months after the first procedure.

Contacts

Public ContactC. Teunissen

Heidelberglaan 100

c.teunissen-2@umcutrecht.nl+3188-7550398

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)